La revista, el nombre con el que está indexado en el medline( si lo está), los años online y la casa editorial
| Expert Review of Pharmacoeconomics & Outcomes Research |
| . |
| Expert Review |
Expert Reviews: Expert Review of Pharmacoeconomics & Outcomes Research: Table of Contents
Table of Contents for Expert Review of Pharmacoeconomics & Outcomes Research. List of articles from both the latest and ahead of print issues.
- Cost–effectiveness of a FISH assay for the diagnosis of melanoma in the USA
Expert Review of Pharmacoeconomics & Outcomes Research , Ahead of Print, Pages 1-10. - Cost–utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain
Expert Review of Pharmacoeconomics & Outcomes Research , Ahead of Print, Pages 1-11. - Vaccination against herpes zoster and postherpetic neuralgia in France: a cost–effectiveness analysis
Expert Review of Pharmacoeconomics & Outcomes Research , Ahead of Print, Pages 1-14. - Irrelevance of explicit cost–effectiveness thresholds when coverage decisions can be reversed
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 163-165. - News in brief
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 167-169. - Cost–effectiveness of natalizumab in multiple sclerosis: an updated systematic review
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 171-182. - Introduction to patient-reported outcome item banks: issues in minority aging research
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 183-186. - Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 187-189. - Application of electronic medical record data for health outcomes research: a review of recent literature
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 191-200. - Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 201-216. - Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: progress, challenges and future directions
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 217-225. - Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 227-235. - Cost–effectiveness of preventive interventions for depressive disorders: an overview
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 237-242. - Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 243-250. - Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 251-259. - Cost–effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 261-270. - Acknowledgements
Expert Review of Pharmacoeconomics & Outcomes Research , April 2013, Vol. 13, No. 2, Pages 271-271.
Buscador de Guías de Práctica Clínica |
|  |
